Skip to main content
Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
201.93
-0.55 (-0.27%)
At close: Dec 5, 2025, 4:00 PM EST
201.98
+0.05 (0.02%)
After-hours: Dec 5, 2025, 7:59 PM EST

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $23.99B in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.

Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
5.28
Revenue / Employee
$667,263
Employees
138,100
Market Cap
486.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Abbott Laboratories 43.84B
Revenue Rankings

JNJ News

More News